In a statement posted to Norton’s website on Aug. 25, officials said on Sept. 8, 2025, the existing contract will end, and ...

Shares of Cigna Group CI rallied 1.13% to $304.35 Friday, on what proved to be an all-around favorable trading session for ...

This proprietary system employs specialized algorithms to identify early signs of litigation trends in federal litigation ...

Cigna Group has been making subtle yet noticeable gains, with its share price now exceeding $300 and showcasing a ...

In filings with the state, insurance companies blamed the price increases on growing health care costs and increasing use of ...

A federal judge is letting a medical practice in New Jersey move forward with a suit over a fax sent by a Cigna subsidiary.

Courts and regulators are signaling that a company’s duty to explain automated decisions is rapidly becoming a standard ...

An upcoming policy from Cigna Healthcare will focus on codes for office visits, but the move is concerning one spine surgeon. Effective Oct. 1, Cigna’s new Evaluation and Management Coding Accuracy ...

CVS Health (CVS) won't include Gilead's (GILD) new HIV drug Yeztugo in its commercial healthcare plans, due to clinical, regulatory and financial factors. Read more here.

The Cigna Group (NYSE:CI) is one of the deep value stocks to buy according to analysts. Cigna’s shares are up about 4% ...

Gilead, its investors, and AIDS activists have high hopes for Yeztugo. Approved in June for people at high risk of HIV, the drug was shown to be nearly 100% effective at preventing infection in large ...

Regulators have also imposed $160,000 in fines on Cigna's Express Scripts unit; $66,000 in fines on Rightway PBM Services; ...